EMA Drops 130 US Manufacturing Site Inspections Under Landmark MRA
Executive Summary
The European Medicines Agency says it is too early to speculate on when the EU will recognize the first US Food and Drug Administration inspection under the mutual recognition agreement signed last year.
You may also be interested in...
Inspection Data Reveals US/EU Mutual Recognition Agreement's Impact On China and India
The agreement reached in the early days of the Trump administration has been putting China and India drug manufacturing in the crosshairs of the world’s leading pharmaceutical inspectorates.
FDA Offers New ‘cGMP Declarations’ That Could Fill US Gap In EU GMP Certificates
US FDA will send ‘cGMP declarations’ to regulatory authorities in other countries where firms want to market drug products made in the US. There is some hope that the declarations will fill in for EU GMP certificates no longer issued for US manufacturing facilities now that there is a US/EU mutual recognition agreement on inspections.
EMA Reports Sharp Reduction In EU GMP Inspections Last Year
EU health authorities inspected fewer drug manufacturing facilities under Europe’s centralized procedure in 2017 thanks to last year’s US/EU mutual recognition agreement, according to a 2017 annual report from the European Medicines Agency. They also found fewer GMP problems at the facilities they did inspect.